Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $1.5B bought by 407 insiders at 258 companies
- $8B sold by 440 insiders outside a trading plan
- $3.9B sold by 789 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past month · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$595M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$154M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$115M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.5M
-
GMEGameStop CorporationRyan CohenCEO$54M
-
FTKFlotek Industries, Inc.Matthew WilksDirector$34.3M
-
GRABGrab Holdings LimitedAnthony Ping Yeow TanCEO$29.9M
-
GSATGlobalstar, Inc.James Monroe IIIDirector$29.8M
-
COURCoursera, Inc.Pale Fire Capital SE10% owner · +4 joint filers$11.4M
Biggest sales
Past month · by insider, all their filings added up · planned sales marked
-
FANGDiamondback Energy, Inc.SGF FANG Holdings, LP10% owner · +1 joint filer$3.7B
-
MDLNMedline Inc.GIC Private Ltd10% owner · +2 joint filers$722M
-
IHTInnSuites Hospitality TrustMarc E BergEVP & Secretary/Treasurer$361M
-
NVDANvidia Corporation ComMark A StevensDirector$300M
-
AVGOBroadcom Inc.Henry SamueliDirector$250M
-
CHYMChime Financial, Inc.DST Global Advisors Ltd10% owner · +9 joint filers$232M
-
UMCUnited Microelectronics CorporationChitung LiuCFO$229M
-
LFSTLifeStance Health Group, Inc.Tpg Gp A, LLC10% owner · +2 joint filers$226M
-
THTarget Hospitality Corp.TDR Capital II Investments LP10% owner · +9 joint filers$202M
-
AURAurora Innovation, Inc.Uber Technologies, Inc10% owner$182M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Alexandros Pappas Insider, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Christopher J Abate CEO, Dashiell I Robinson President, Greg H Kubicek Director, Brooke Carillo CFO, +2 more
-
Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Kimberly J Brumbaugh Director, +2 more
-
Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more
-
Thomas Jon Hammond Director, Sandip I Patel CFO, John Martin Schaible Chair, David Craig Ridenhour President, +1 more
-
John B Williamson III Director, Robert B Johnston Director, Paul W Nester CEO, Lawrence T. Oliver Senior VP and Secretary, +1 more
-
Kourosh Nasser Zamanizadeh Director, Bessie Ross Wills Director, Nicole Sherman CEO, Stacey Graham Director, +1 more
-
Joseph D Sarafa Director, Brian J Roney CEO, James Grant Smith Director, Harold J Meloche CFO
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Ugur Sahin CEOBNTXBioNTech SEPlanned sale$6M 61,000 shares at $98.57 18% of stakeTraded Sep 25–28 Filed Sep 28
-
Robert I Blum CEOCYTKCytokinetics, IncorporatedPlanned sale$491K 7,500 shares at $65.46 2.6% of stakeTraded Sep 28 Filed Sep 28
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.5M 9,500 shares at $476.17 2.8% of stakeTraded Sep 25 Filed Sep 28
-
George Kurian CEONTAPNetApp, Inc.Planned sale$7.4M 37,000 shares at $199.95 12% of stakeTraded Sep 24 Filed Sep 28
-
Luis Von Ahn CEODUOLDuolingo, Inc.Planned sale$7M 46,682 shares at $150.63 100% of stakeTraded Sep 24 Filed Sep 28
-
Luis A Muller CEOCOHUCohu, Inc.Planned sale$1.8M 27,236 shares at $65.00 3.1% of stakeTraded Sep 25 Filed Sep 25
-
Rajeev K. Goel CEOPUBMPubMatic, Inc.Planned sale$931K 50,453 shares at $18.45 100% of stakeTraded Sep 24 Filed Sep 25
-
Cristiano R Amon CEOQCOMQUALCOMM IncorporatedPlanned sale$2M 10,000 shares at $200.00 5.3% of stakeTraded Sep 25 Filed Sep 25
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.5M 9,500 shares at $473.55 2.8% of stakeTraded Sep 24 Filed Sep 25
-
August J. Troendle CEOMEDPMedpace Holdings, Inc.Sale$27.4M 43,916 shares at $624.01 10% of stakeTraded Sep 23–24 Filed Sep 25
-
Olivier Loeillot CEORGENRepligen CorporationPlanned sale$2.5M 12,946 shares at $190.00 21% of stakeTraded Sep 24 Filed Sep 25
-
Emily M. Leproust CEOTWSTTwist Bioscience CorporationPlanned sale$923K 5,203 shares at $177.38 0.8% of stakeTraded Sep 24 Filed Sep 25
-
Laurel Hurd CEOTILEInterface, Inc.Planned sale$245K 7,000 shares at $34.99 1.4% of stakeTraded Sep 24 Filed Sep 25
-
Or Offer CEOSMWBSimilarweb Ltd.Planned sale$879K 114,300 shares at $7.69 2.8% of stakeTraded Sep 24 Filed Sep 25
-
George Kurtz CEOCRWDCrowdStrike Holdings, Inc.Planned sale$5.1M 20,000 shares at $253.17 0.3% of stakeTraded Sep 22–23 Filed Sep 24
-
Michael N Intrator CEOCRWVCoreWeave, Inc.Planned sale$26.7M 307,692 shares at $86.82Traded Sep 22 Filed Sep 24
-
Joseph Devivo CEOBFLYButterfly Network, Inc.Planned sale$60K 5,980 shares at $10.01 0.1% of stakeTraded Sep 22–23 Filed Sep 24
-
Robert Mionis CEOCLSCelestica, Inc.Planned sale$8.5M 23,396 shares at $364.22 100% of stakeTraded Sep 23 Filed Sep 24
-
Todd McKinnon CEOOKTAOkta, Inc.Planned sale$9.4M 48,822 shares at $193.48 100% of stakeTraded Sep 22 Filed Sep 24
-
Vladimir Tenev CEOHOODRobinhood Markets, Inc.Planned sale$30.2M 240,834 shares at $125.33 100% of stakeTraded Sep 22 Filed Sep 24
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.7M 9,500 shares at $491.57 2.8% of stakeTraded Sep 23 Filed Sep 24
-
Serge Saxonov CEOTXG10x Genomics, Inc.Planned sale$2M 25,000 shares at $81.22 2.3% of stakeTraded Sep 22 Filed Sep 24
-
Ugur Sahin CEOBNTXBioNTech SEPlanned sale$6.8M 69,000 shares at $99.17 17% of stakeTraded Sep 23–24 Filed Sep 24
-
Gary Bowman CEOBWMNBowman Consulting Group Ltd.Planned sale$2.6M 60,000 shares at $42.55Traded Sep 23 Filed Sep 24
-
Eric P Lefkofsky CEOTEMTempus AI, Inc.Planned sale$19.4M 250,000 shares at $77.47 71% of stakeTraded Sep 22 Filed Sep 24
-
Jonathan Shar CEOBNEDBarnes & Noble Education, IncSale$331K 30,000 shares at $11.04 8.4% of stakeTraded Sep 22 Filed Sep 24
-
Abraham Ceesay CEORAPPRapport Therapeutics, Inc.Planned sale$87K 2,210 shares at $39.17 0.5% of stakeTraded Sep 23 Filed Sep 24
-
Or Offer CEOSMWBSimilarweb Ltd.Planned sale$531K 62,900 shares at $8.45 1.5% of stakeTraded Sep 22–23 Filed Sep 24
-
Michael D. Sicilia CEOORCLOracle CorporationPlanned sale$3.4M 22,562 shares at $151.59 11% of stakeTraded Sep 22 Filed Sep 23
-
Jonathan Klamkin CEOALMUAeluma, Inc.Planned sale$1.3M 100,000 shares at $13.35 7.5% of stakeTraded Sep 21 Filed Sep 23
-
Daniel Mark Rogers CEOASANAsana, Inc.Planned sale$1.4M 150,175 shares at $9.13 9.2% of stakeTraded Sep 22 Filed Sep 23
-
Luis Von Ahn CEODUOLDuolingo, Inc.Planned sale$6.2M 40,980 shares at $150.65 100% of stakeTraded Sep 21–22 Filed Sep 23
-
D James Bidzos CEOVRSNVerisign Inc.Planned sale$1M 3,300 shares at $304.74 0.8% of stakeTraded Sep 22 Filed Sep 23
-
Joshua J. Ofman CEOGRALGRAIL, Inc.Planned sale$6M 61,452 shares at $97.74 15% of stakeTraded Sep 21 Filed Sep 23
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.7M 9,500 shares at $494.83 2.8% of stakeTraded Sep 22 Filed Sep 23
-
George Kurian CEONTAPNetApp, Inc.Planned sale$2.6M 13,000 shares at $200.01 4.1% of stakeTraded Sep 21 Filed Sep 23
-
Cristiano R Amon CEOQCOMQUALCOMM IncorporatedPlanned sale$2M 10,000 shares at $195.00 5.1% of stakeTraded Sep 21 Filed Sep 23
-
Bryan Leach CEOIBTAIbotta, Inc.Planned sale$626K 15,142 shares at $41.34 1.8% of stakeTraded Sep 21–22 Filed Sep 23
-
John T Hall CEOINTAIntapp, Inc.Planned sale$110K 3,000 shares at $36.74 0.1% of stakeTraded Sep 21 Filed Sep 23
-
August J. Troendle CEOMEDPMedpace Holdings, Inc.Sale$44.4M 70,901 shares at $626.62 14% of stakeTraded Sep 21–22 Filed Sep 23
-
Vladimir Tenev CEOHOODRobinhood Markets, Inc.Planned sale$32.5M 259,166 shares at $125.58 100% of stakeTraded Sep 21 Filed Sep 23
-
Scott A. Lang CEOATEXAnterix Inc.Planned sale$1.2M 15,000 shares at $80.00 36% of stakeTraded Sep 21 Filed Sep 23
-
George Kurtz CEOCRWDCrowdStrike Holdings, Inc.Planned sale$753K 3,014 shares at $249.86 <0.1% of stakeTraded Sep 21 Filed Sep 22
-
George Kurtz CEOCRWDCrowdStrike Holdings, Inc.Planned sale$19.5M 81,501 shares at $239.77 1.1% of stakeTraded Sep 21 Filed Sep 22
-
Ian H. Siegel CEOZIPZipRecruiter, Inc.Planned sale$202K 54,422 shares at $3.71 21% of stakeTraded Sep 18–22 Filed Sep 22
-
Padmanabhan T Srinivasan CEODOCNDigitalOcean Holdings, Inc.Planned sale$1.6M 11,394 shares at $140.00 1.5% of stakeTraded Sep 21 Filed Sep 22
-
Brian E O'Toole CEOBKSYBlackSky Technology Inc.Planned sale$458K 20,000 shares at $22.88 1.9% of stakeTraded Sep 21 Filed Sep 22
-
Ugur Sahin CEOBNTXBioNTech SEPlanned sale$7.9M 79,000 shares at $99.50 16% of stakeTraded Sep 21–22 Filed Sep 22
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.7M 9,500 shares at $494.55 2.8% of stakeTraded Sep 21 Filed Sep 22
-
Mac Armstrong CEOPLMRPalomar Holdings, Inc.Planned sale$472K 3,500 shares at $134.98 1.1% of stakeTraded Sep 21 Filed Sep 22
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.